(Q34057466)
Statements
1 reference
Phase I safety, pharmacokinetics, and pharmacogenetics study of the antituberculosis drug PA-824 with concomitant lopinavir-ritonavir, efavirenz, or rifampin (English)
1 reference
Anne F Luetkemeyer
1 reference
Susan L Koletar
1 reference
Kelly E Dooley
1 reference
Jeong-Gun Park
1 reference
Reena Allen
1 reference
Yoninah Cramer
1 reference
Stephen Murray
1 reference
Deborah Sutherland
1 reference
Francesca Aweeka
1 reference
Florence Marzan
1 reference
Jing Bao
1 reference
Rada Savic
1 reference
David W Haas
1 reference
AIDS Clinical Trials Group A5306 Study Team
1 reference
23 June 2014
1 reference
1 reference
58
1 reference
5245-5252
1 reference
Identifiers
1 reference
1 reference
1 reference